Position in SNDX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$41,397,374
+$14,447,832 QoQ
Shares Held
1,893,750
+64.2% QoQ
Ownership
2.12%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#15
of 242 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in SNDX Over Time
Shares Held
Position Value (USD)
Derivatives in SNDX
reported options exposure · as of Dec 31, 2025CallValue
$1,519,023
CallShares
72,300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. SNDX ranks #42 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in SNDX
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,397,374 | 1,893,750 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $26,949,542 | 1,153,662 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $15,047,760 | 716,219 | Shares | Defined | 2026-01-29 | |
| 2025-12-31 | $1,519,023 | 72,300 | Call | Defined | 2026-01-29 | |
| 2025-09-30 | $25,762,381 | 1,674,513 | Shares | Defined | 2025-11-13 | |
| 2025-09-30 | $1,112,335 | 72,300 | Call | Defined | 2025-11-13 | |
| 2025-06-30 | $13,442,661 | 1,435,415 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $21,078,332 | 1,715,778 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $13,601,012 | 1,028,821 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $264,400 | 20,000 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $2,818,931 | 146,438 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,569,370 | 125,152 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,421,501 | 269,811 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $6,284,208 | 290,801 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $287,496 | 19,800 | Put | Sole | 2023-11-09 | |
| 2023-09-30 | $871,200 | 60,000 | Call | Sole | 2023-11-09 | |
| 2023-09-30 | $1,094,183 | 75,357 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $2,359,145 | 112,716 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,287,611 | 108,315 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $4,397,377 | 172,785 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $6,861,333 | 285,532 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $6,092,826 | 316,675 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $3,739,549 | 215,164 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,075,915 | 140,517 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,347,503 | 70,513 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $315,447 | 18,372 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,416,997 | 63,372 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $259,406 | 11,664 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $14,760 | 1,000 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $445,533 | 30,063 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $174,170 | 15,877 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||